Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 9 lis 2017 · During the study period from 5 to 20 years, the absolute risk of distant recurrence among patients with T1N0 breast cancer was 10% for low-grade disease, 13% for moderate-grade disease,...

  2. 15 lut 2023 · Breast cancer–specific survival at 10 years was 97.4% (95% CI, 96.0 to 98.8) among patients assigned to no radiotherapy and 97.9% (95% CI, 96.5 to 99.2) among patients assigned to radiotherapy...

  3. 25 sty 2022 · Historically, only a minority of patients with metastatic breast cancer survived beyond 10 years . In recent times, expected survival has greatly improved, with data from the Surveillance, Epidemiology and End Results (SEER) suggest 5-year survival in the setting of metastatic disease to be 27% .

  4. 12 lis 2011 · Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

  5. 17 lip 2021 · With improved early diagnosis and advanced treatment approaches, current survival is high with 5- and 15-year relative survival rates of 91% and 80% (Breast Cancer Facts and Figures 2019 – 2020), respectively.

  6. 12 lis 2011 · Overall, radiotherapy reduced the 10-year risk of any (ie, locoregional or distant) first recurrence from 35·0% to 19·3% (absolute reduction 15·7%, 95% CI 13·7–17·7, 2p<0·00001) and reduced the 15-year risk of breast cancer death from 25·2% to 21·4% (absolute reduction 3·8%, 1·6–6·0, 2p=0·00005).

  7. 8 lis 2001 · Several randomized clinical trials 1–5 and a meta-analysis 6 have shown similar survival rates after breast-conserving therapy and after mastectomy in patients with early breast cancer.